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The Carbonic Anhydrases: Widening 
Perspectives on Their Evolution, 
Expression and Function 
Richard E. Tashian 
Sum ma ry 
Now, some 55 years after its discooery in 
bovine red cells, carbonic anhydrase 
(CA),  in all its variedforms, continues to 
challenge and intrigue physiologists, hio- 
chemists and molecular geneticists. This 
is so because oJ an increasing awareness 
of the many appurently dicerse,functions 
of the diflerent CA isozymes encoded by 
this large multigene family, the con- 
tinuing discovery of new CA, or CA- 
related, genes, and the extensive variation 
in their hormonal control, cellular ex- 
pression and subcellular localization. 
Introduction 
The carbonic anhydrases (CA) are zinc 
metalloenzymes that catalyze the simple 
interconversion of CO, and HC0,- 
(CO, + 0, $ HC0,- + H+). They are 
found in almost all organisms, and are 
notable for the extremely high turnover 
numbers (some exceeding 1 x lofi sec-') 
of the high-activity forms, ranking them 
along the most efficient enzymes known. 
They are also distinctive because of the 
extensive diversity in both the cellular 
distribution and in the putative or 
established biological functions of the 
seven CA isozymes now known to occur 
in higher vertebrates. Some of the CA 
genes are expressed in certain cells of 
nearly all tissues, whereas others appear 
to be more limited in their distribution. 
In view of such diversity in expression 
and function, the CA isozyme system is 
an excellent model for the study of 
molecular processes and patterns under- 
lying the evolution and expression of 
genes derived from a common ancestor. 
(for recent accounts, see papers in refs. 
1 and 2.) 
Evolutionary Patterns 
Since the reaction catalyzed by carbonic 
anhydrase may well have been of wide- 
spread adaptive value to the earliest 
organisms, it is possible that it was 
among the first enzymes to appear. 
Since what seem to be evolutionarily 
related (homologous) forms of carbonic 
anhydrase are found in certain bacteria 
and algae,3 the original gene probably 
arose before the divergence of pro- 
karyotes and eukaryotes more than one 
and a half billion years ago. And during 
their long evolutionary history the CA 
genes have undergone many rounds of 
duplications resulting in new genes, the 
products of which have been implicated 
in such diverse processes as calcification, 
photosynthesis, respiration, acid-base 
homeostasis, bone resorption, forma- 
tion of aqueous humor and gastric juice, 
and the synthesis of urea, glucose and 
lipids.lI2 
The Genes 
In terrestrial vertebrates (i.e. amniotes) 
the carbonic anhydrase system com- 
prises at  least 7 genes (Table I). Four of 
these (coding for CA I, CA 11, CA III 
and CA VII) have now be fully or 
partially characterized,"R and with the 
exception of human CA I, which has a 
large intron in the 5' untranslated 
region,* they all appear to have seven 
exons, with the six introns at the same 
positions, and range in size from 9.8 kb 
(human CA VII) to 17 kb (chicken and 
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TABLE I. Summary of selected.features c$ the mammalian CA isozymes and Eiral CA-like proteins* 
CA I 260 Low ( 5  1 x lo5) Human 8q22 
Mouse 3 
CA 111 259 Low (- 1 x lo4) Human 8q22 
Amino acid Activity Chromosome Some established and 
residues (mol sec-') position Distribution purported functions 
- - - -___________ ~~ - ~ 
CA Isozymes 
Cytosolic 
CA 11 259 High ( -  1 x lo6) Human 8q22 Widely distributed in secretory Promotion of gas, fluid and ion 
Mouse 3 and absorbing epithelia. Certain transfer. Maintenance of acid- 
base homeostasis. H' secretion 
(gastric juice production, renal 
acidification, bone resorption). 
HCO, ~ secretion (production of 
pancreatic juice, CS fluid, 
acqueous humor, saliva). 
HC0,- reabsorption, (proximal 
renal tubules). CO, excretion 
and exchange. Ca' transport 
(placenta). Fatty acid and amino 
acid synthesis. C1- exchange 
cells of virtually all tissues [e.g. 
bone (osteoclasts). braint 
(oligodendrocytes), eye (ciliary 
body, lens, Miiller cells of 
retina), liver (perivenous cells), 
kidney (tubules). salivary glands 
(acinar cells), pancreas (ductal 
cells). stomach (parietal cells) 
and uterus]. Red cells and 
platelets. Undetected in 
granulocytes. monocytes, 
fibroblasts, osteoblasts, and (colon)? 
CNS neurons 
gastrointestinal epithelia and 
vascular endothelium. Also in 
such tissues as: eye (corneal 
endothelium. lens and ciliary 
body epithelium), sweat glands, 
salivary glands, adipose cells 
and myoepithelial cells 
Mainly in red skeletal muscle 
(type 1). Also in liver of non- 
primates (esp. male rat), salivary 
glands, smooth muscle (uterus), 
red cells, prostate gland, lung, 
kidney, brain colon, testis, 
mammary gland, and white fat 
cells 
Primarily in red cells, Probably similar to CA I 1  
functions. Possible unique roles 
in endothelial cells of capillaries 
and eye (cornea and lens). 
Absorption of NH, in rumen 
and colon? 
Facilitation of co, diffusion. 
Role in muscle contraction? 
Acid-base homeostasis (liver) 
CA VII 263 ? Human 16q21-23 Salivary gland (?) ? 
Membrane- bound 
High ? Lung (capillary endothelium), Reabsorption of HCO, in CA 1V ? 
(glycoprotein) kidney (brush border of tubular proximal renal tubules. 
cells). Probably also in other 
tissues (e.g. muscle, liver, 
gastrointestinal mucosa) 
Transport of H' and HC0,-  in 
capillary endothelium of lung, 
and Facilitation of CO, transfer. 
Cat+ exchange (muscle)? 
Mitochondria1 
CA V '? High ? Kidney and liver. Probably in Provide HCO,- for initial steps in 
many other tissues (e.g. muscle, 
gastric mucosa) 
gluconeogenesis (e.g. liver & 
kidney), and ureagenesis (liver) 
Secreted 
CA VI 314 High and Human lpt36 Salivary glands (acinar cells) Regulation of salivary pH? 
(glycoprotein low 
CA 'Y'  262 ? ? Mouse liver (possibly CA V) ? 
Unknown 
Viral CA-like proteins 
D8 product 304 - - Vaccinia virus (transmembrane ? 
erb-A (domain 2) 164 - - Avian erythroblastosis virus c-arb-A (thyroid hormone 
protein) 
product1 receptor) 
* Sources for this table compiled largely from refs, 1 and 2 and citations therein. Additional data for CA isozymes: CA l'.', CA 11". p 4 , 4 2 ,  CA l I 1 8 . 9 ~  p 4 . 4 2 ,  
CA IV (W. S. Sly, unpublished), CA VI3'."', CA VJII', CA 'Y'  is a tentative designation, sequence derived from mouse liver mRNA (M. Amor & T. Meo, 
unpublished). Viral sources: AEV erb-A,16~17 vaccinia D8'4,'5. 7 50 "" membrane-bound (rat). 1 Homology to CA genes uncertain. 
human CA 11). The human CA I gene 
contains an unusually long 5' non- 
coding region of about 37 kb, making it 
about 3-5 times larger than the other 
CA genes. Because the evolutionary 
origin of the intron which interrupts 
this 5' region is of interest, it will be 
useful to know to what extent it is also 
characteristic of the CA I genes from 
other, especially non-mammalian, 
sources. 
The human CA I, CA I1 and CA I11 
genes are linked on chromosome 8,'.1° 
whereas the genes for CA VI and CA 
VII are located on chromosomes 1 and 
16, re~pectively.'.'~ Since the CA I, CA 
I1 and CA 111 genes are present in birds 
and mammals,12 they must have been 
formed prior to the divergence of 
reptiles and mammals about 300 million 
years ago, and have remained linked in 
the mammalian lineage since that time. 
In view of the dispersion of the CA 
genes to at  least three chromosomes, it 
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* Determined from arithmetic means of pairwise comparisons of 6 mammalian CA 1’s and CA 11’s. 
5 CA IIl’s, human CA IV and mouse CA ‘Y’,  sheep CA VI, human CA VII, vaccinia D8, and human 
c-erb-A. Sequences for CA I ,  CA I1 and CA I11 isozymes are from ref. 11, plus mouse CA I:’*, mouse 
CA 111 (Y. Edwards, unpublished) and horse CA III”. References for other sequences are: human CA 
VII,’ mouse CA ‘Y’  (M. Amor & T. Meo, unpublished), vaccinia virus D8,13 sheep CA VI,37 human 
CA IV (W. S. Sly & C. X. L. Zhu, unpublished) and erh-A, domain 2.“j Insertions and deletions were 
introduced to maximize the number of matches in the comparisons. 
will now obviously be of interest to 
determine the chromosomal locations 
of the membrane-bound CA IV and 
mitochondrial CA V genes. Possibly, 
detailed analyses at the DNA level of 
the flanking regions of the CA I, I1 and 
I11 genes will eventually provide clues 
concerning the importance of common 
regulatory elements as selective factors 
in maintaining gene linkages. Prelimi- 
nary studies in our laboratory indicate 
that in humans these genes are arranged 
in the 5’ to 3’ order (CA I, CA 111, CA 
11) within a span of less than 180 
kilobases (P. J. Venta, unpublished, and 
ref. 13). 
Although the structures of CA genes 
from plants and lower organisms have 
not been characterized, it is interesting 
to note that a CA-like gene (DS), devoid 
of introns, and encoding 304 amino 
acids, has been found in vaccinia virus.14 
When the derived amino acid sequence 
is compared to the sequences of the 
cellular CA isozymes, the percent 
identity ranges from 37y0 to 29:/, 
(Table 11). This viral gene product, 
however, probably lacks CA activity 
(see discussion of active sites below). 
Recent studies have demonstrated that 
the product of the D8 gene is a 
transmembrane protein with a major 
extraviral, CA-like domain which is 
non-essential for viral pr0pagati0n.l~ It 
will be especially interesting to dissect 
the evolutionary history of the vaccinia 
D8 gene by examining other pox viruses. 
Another virus which possibly contains 
a CA-related gene is avian erythro- 
blastosis virus (AEV),“ in which the 3’ 
portion (domain 2) of its erb-A gene may 
be homologous to a region spanning 
residues 10-1 83 (based on CA I number- 
ing)” of the 261 residues characteristic 
of the CA I, CA I1 and CA I11 
isozymes.’2 It is now known that the 
human and chicken cellular c-erh-A 
gene encodes a thyroid hormone re- 
ceptor,” the C-terminal, hormone-bind- 
ing segment of which shows some 
apparent similarity (not statistically sig- 
nificant) to the region (positions 10-183) 
of the CA sequences just discussed. 
Thus, c-erb-A may be a hybrid gene 
deriving its 3‘ hormone-binding half 
from a portion of a CA gene, and its 5’ 
DNA-binding region from some other 
source. 
Phylogenetic Relationships 
To date, amino acid siquences have 
been determined, or inferred from DNA 
sequences, for the CA I ,  CA I1 and CA 
I11 isozymes from a number of species,12 
as well as sequences from single species 
for the more recently characterized CA 
isozymes, CA VI, CA VII and CA ‘Y ’. 
CA ‘ Y ’  is a tentative designation for a 
CA isozyme whose sequence was de- 
rived from mouse-liver mRNA (M. 
Amor & T. Meo, unpublished). Because 
its sequence does not closely resemble 
any of the other mouse CA isozymes 
(Table HI), it is possible that it repre- 
sents the mitochondria1 isozyme, CA V 
(see below). 
A matrix has been prepared com- 
paring the consensus amino acid sequen- 
ces for CA I, CA I1 and CA 111, along 
with those for CA IV, CA VI, CA VII, 
CA ‘Y’ and the two viral CA-like genes 
(Table 11). As can be seen, there is a 
59 percent identity between the CA I 
and CA I1 sequences, with an apparent 
decrease in evolutionary relatedness 
when comparisons are made with other 
CA and CA-like sequences in the order : 
I Amniotes 
L C A  111 
r::::-CA 1 1 1  (consensus) 
CAVI I  Human 
r’-,A ‘y’ Mouse 
D8 Vaccinia . 
,. 
-I , 
/ I  ., 
I C A V I  Sheep 
Fig. 1. Generalized phylogenetic brunching scheme 
for the CA isozymes of amniotes and the uaccinia 
D8 protein. Based on amino acid sequences cited in 
Table I / .  
CA 111, CA VII, CA ‘Y’, vaccinia D8, 
CA VI, CA IV and erb-A. With the 
exception of the latter two, these CA and 
CA-related sequences were also used 
to construct the generalized branch- 
ing scheme shown in Fig. 1 utilizing 
a .maximum parsimony algorithm for 
determining ancestral sequences.12 As 
shown with the matrix analysis, there is 
a similar order of evolutionary re- 
latedness of the CA genes, with the 
salivary CA VI gene appearing to have 
diverged first from the ancestral root. 
The Active Sites 
Because the three-dimensional struc- 
tures of human CA I and CA 11 and 
bovine CA 111 have been deter- 
mined,18, ’’ i t  is possible to compare 
residues presumed to be located within 
the active sites of the different CA 
isozymes (Table 111). Of the 36 residues 
at homologous positions, 17 (47 yo) are 
invariant. Of the other residues, all 
expect the tiger shark red-cell CA have 
at  least one residue that seems to be 
unique and invariant for that isozyme. 
To what extent these residues contribute 
to the catalytic variation noted among 
the different isozymes is difficult to 
assess. For example, CA 111 is a low- 
activity isozyme which is not strongly 
inhibited by sulfonamides,20 and it is 
tempting to attribute these feature to 
one or more of its eight unique residues, 
especially the basic residues, Arg and 
Lys, at positions 64, 67 and 91. How- 
ever, when His-64 was replaced by Lys 
in human CA I1 by site-directed muta- 
genesis, no appreciable reduction in its 
CO, hydrase activity at pH 8.8 was 
observed.21 This was unexpected, be- 
cause His-64 was thought to play an 
important role in the transfer of protons 
from the active site in the inter- 
conversion of CO, and HC0,-.22 An- 
other possibility is that the unique Phe- 
198 residue may modify the function of 
the Thr- 199/Glu- 106 complex which 
has been strongly implicated in the 
catalytic process.22 Also, the unique 
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TABLE III .  Residues postulated to occur within the active sites of animal carbonic anhydruses compared with vaccinia 08  protein" 
- -  
V W I N . R  
V W I N R  
V W I N R  
V W I N R  
V W V N R  
V W I N R  
V W V N R  
V W V N R  
V W V N R  
V W V N R  
V W V N R  
V W V N R  p$; 
I W L N R .  
V W V N R a  
V W V N R  
V W V N R  
V W V N R  
V W V N R  
A W I N R  
Y L  
CA Forms' 
Human CA I 
Rabbit CA I 
Mouse CA I 
Ox CA I 
Horse CA I 
Turtle CA I 
V H S F H N F Q H H E H E H A L L V  
V H S F H N S Q H H E H E H V I L I  
V H S F H I T Q H H E H E H V A L I  
V H S F H N F Q H H E H E H V F L L  
V H S F Q K V Q H H E H E H V F L I  
V H S F H N Q Q H H E H E H V F L L  
Human CA I1 
Rabbit CA I1 
Mouse CA I1 
Ox CA I1 
Horse CA I1 
Chick CA I1 
- 
W Y L  
W Y L  
W Y L  
W Y L  
W Y L  
W Y L  
Human CA 111 
Mouse CA I11 
Ox CA 111 
Horse CA I11 
Shark CA 
Mouse CA "Y" 
Human CA VII 
Sheep CA VI 
Human CA VI 
Vaccinia D8 
- 
P P Y  
P P H  
P P H  
P P L  
P P Y  
P P F  
Residue numberb 
1 1 1 1 1 1 1 1  
2 6 6 6 6 6 6 6 9 9 9 9 0 0 1 1 2 3 4 4  
7 9 1 2 4 5 6 7 9 1 2 4 6 6 7 7 9 1 1 1 3  
T H  'w T H  
T T  
T T  
T T  
T T  
T T  
T T  
T T  
T T  
T T  
T T  
T T  
T T  
T T  
T T  
T T  
T T  - 
r 
Y S N  
Y S N  
Y S N  
Y S N  
Y S N  














1 2  
9 0  
9 0  
t t  
2 2 2  
0 0 0  
1 2 4  












2 2 2 2 2  
0 0 1 4 4  
7 9 1 4 6  
t *- Y 
a Based on tertiary structures of human CA I, CA I1 and bovine CA III.'7.'' 
' Sequence sources are as in legend for Table 11. Tiger-shark sequence from N. Berhenhem & U. Carlsson (unpublished). Residues common to all animal 
sequences (including vaccinia) have been boxed. Other boxes indicate invariant and unique residues for CA isozymes of aminiotes. Dashed box at position 
64 for CA 111's indicates unique basic residues. Residues forming hydrogen-bond network to Zn-bound solvent molecule, or to the three Zn-liganded His 
residues (designated, Zn), in human CA I and CA I1 and bovine CA 111 (cf. refs.17, 18) are designated by an asterisk (*). 
Based on CA 1 numbering." 
Cys-66 residue could conceivably con- 
tribute to the characteristic properties 
of the CA 111 isozymes. Almost cer- 
tainly, results from other site-directed 
mutageneis studies will provide further 
insights into the active site mechanisms 
of the CA isozymes. 
The antiquity of the active-site struc- 
ture is suggested by an examination of 
the residues found in the red-cell CA of 
the tiger shark (Table III), a carti- 
laginous fish which arose around 450 
million years ago. Although the residues 
at  positions 64-69 have not been de- 
termined, the shark CA has retained an 
active-site structure differing little from 
those of the cystolic CA isozymes of 
amniotes. However, since this repre- 
sents the first structure of a non- 
amniotic CA, it would be premature to 
say that the active-site residues of the 
shark CA are representative of the 
ancestral structure. 
Unfortunately, no clues are evident 
concerning the evohtion of the active 
sites by simply examining the structural 
regions coded by exons. As shown in 
Table 111 and Fig. 2, residues associated 
with the active sites are coded on all but 
one exon, and the three, His residues 
binding the essential zinc ion are coded 
on exons 2 and 3. In view of the 
observations from several studies that 
exons encode various domains of pro- 
teins, it is notable that no similar 
correlation is evident when the exonic 
regions of mammalian and avian CA I1 
genes are compared with the structural 
or functional features of the CA I1 
molecules (Fig. 2). 
It is also noteworthy that the CA- 
related gene, D8, from the vaccina virus 
has retained 600/, of the active site 
residues found in the cellular CA iso- 
zymes (Table 111). However, because 
certain crucial residues are not present, 
such as the zinc-binding His residues at  
positions 96 and 119, the possibility 
that this viral protein has CA activity is 
extremely remote. 
Hormonal and Neuronal Control 
Early studies indicated that the activities 
or levels of CA I and CA I1 in various 
mammalian tissues could be influenced 
by thyroxine (red blood cells), sex 
hormones (endometrium, accessory sex 
glands), cyclic AMP-mediated action of 
epinephrine (red blood cells), and pro- 
lactin (pituitary gland).3 
Recently, it was shown that pituitary 
growth hormone (GH) has a differential 
effect on the levels of CA 111 in rat liver, 
where the amount of CA 111 in the male 
can be 15-20 times greater than in the 
female.23 Initially, this was thought to 
be due to the induction of CA 111 by 
testosterone; however, recent studies 
indicate that CA 111 is suppressed in the 
female liver by the continuous action of 
GH, whereas the pulsatory release of 
G H  in the male does not noticeably 
suppress the levels of CA No 
similar effect of G H  on CA 111 was seen 
in muscle where the levels of CA 111 are 
the same in males and females. It is 
noteworthy that CA I11 (as well as CA 
11) in rat liver as determined by immuno- 
fluorescence is concentrated in hepatb- 
cytes surrounding the central vein.'4 In 
these perivenous cells, the staining in- 
tensity of CA 111 is markedly higher in 
males than in females, whereas the 
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Fig. 2 .  Schematic representation of the three-dimensionul ,structure of humun carbonic anhydrase I I  
(abooe), and separated structures of the segments encoded by the seven exons of human and mouse CA I I  
genes (below). Beta strunds are designured by arrows. Bused on the human CA I the numbering 
of the residues encoded by these exons are: exon 1 (residue,s I 12), exon 2 (12 78), e.wn 3 (78-1 17), 
exon 4 ( 1  18-149). exon 5 (150--170), exon 6 (171 222) and exon 7 (223--260). The His residues ut 94. 96 
and 119 forming ligands to the active-.site Zn ion are indicuted hy .solid circles (0). The tertiary structure 
of C A  II  is based on Fig. 3 in ref. 22 originally drawn by Anders Liljus. 
opposite is true for CA TI, which stains 
more intensely in females than in males. 
Changes in the levels of CA 111 in rat 
skeletal muscle brought about by hypo- 
and hyperthyroid conditions seem to 
depend on the type and amounts of the 
different fibers. The increase in CA 111 
resulting from thyroidectomy was due 
not only to an increase in the slow- 
twitch type-I fibers (which normally 
express CA III), but also in a subtype of 
type 2A fibers (which do not normally 
express CA Treatment with thy- 
roid hormone brought about a decrease 
of CA 111 in type-1 fibers, and an 
increase in CA 111 in type 2A fibersz6 
These variations in the expression of 
CA 111 in the different fiber types to 
varying thyroxine levels are difficult to 
interpret at  present. It is of interest that 
a similar response to thyroxine levels 
has been noted for CA I in human and 
mouse red cells in that hyper- and 
hypothyroidism results in increased and 
decreased levels, respectively, of CA I.3 
Neuronal control of CA 111 in rat and 
rabbit skeletal muscle has also been 
shown by the demonstration of in- 
creased levels of CA 111 after denerva- 
t i ~ n , , ~  or the continuous stimulation of 
an innervating nerve.2u Interestingly, 
the elevated levels are more pronounced 
in type-2 fibers, where FA I11 is not 
normally expressed, than in type 1 
fibers, where they are normally present. 
Possibly type 2 fibers are replaced by 
type 1 and superimposed 0'1 this may be 
the induction of CA 111 in pre-existing 
fibers. Although the mechanism for this 
increase in CA I11 is not clear, it is 
possible that CA 111 is suppressed to 
some extent by a growth factor secreted 
by nerve endings, and in the absence of 
this factor, CA I11 levels are increased 
in a manner similar to the increase of 
CA 111 in female rat liver on hypo- 
physectomy.23 
Other examples of hormonal control 
of CA have been the recent demon- 
stration of androgen regulation of CA 
IT in rat prostate,28 and the modulation 
of CA I1 by calcium-regulating hor- 
mones (calcitonin and parthyroid hor- 
mone) in human red blood cells.*' 
Diversity in Expression and 
Function 
Although the CA isozymes are known 
to possess activities other than the 
reversible hydration of CO, (e.g. car- 
boxylesterase, aldehyde hydratase, 
phosphatase)," physiological roles, if 
any, for these activities have not been 
established. Thus it is the simple re- 
versible hydration of H+ and HC0,- 
from CO, and H,O which is the basis 
for the numerous putative and estab- 
lished physiological roles of the CA 
isozymes (Table I). This functional 
diversity appears to be mostly associ- 
ated with the widely distributed high- 
activity CA I1 isozyme and to some 
extent with CA I. Although CA 111 is 
found mainly in skeletal muscle, it is 
also expressed in hepatocytes (as dis- 
cussed above) and at low levels in certain 
other cells. In muscle, CA 111 has been 
implicated in the facilitated transport of 
C02,20 and is also thought to have a 
role in the slow-twitch contractile ap- 
paratus of type-1 fibers.26 CA 111 does 
not seem to be associated with any 
subcellular structures of the muscle cell 
such as mitochondria, nuclei, triads and 
Z and M  band^.^" It is difficult to 
understand why the low-activity CA 111 
isozyme is needed in muscle and liver; 
however, because CA 111 possesses low 
acid phosphatase activity, it is possible 
that it may function in a role different 
from, or in addition to, that of facili- 
tating CO, diffusion.'" The clustering of 
CA I1 and CA I11 around the venous 
wall in liver suggests that the acid- 
secreting hepatocytes regulate protein 
and HCO,- secretion into the blood, 
implicating a role in acid-base balance.24 
The other isozymes (CA IV, CA V, CA 
VI and CA VII) seem to be more 
restricted in their cellular or subcellular 
expression. Although the membrane- 
bound CA IV form is known to occur in 
kidney (brush border of luminal cells) 
and lung (endothelium), it seems likely 
that it will be found in other tissues as 
well. As of now, the greatest number of 
expressed CA genes that have been 
reported are apparently expressed in 
the salivary glands. These are: the 
cytosolic CA I, CA IT and CA 111 
forms, the secreted CA VI form, and 
the newly discovered isozyme CA VII,' 
previously designated CA 'Z' (Table I). 
Why are four, non-secreted, cytosolic 
forms of CA needed to carry out their 
putative roles in fluid and ion transport? 
Of course, a similar question can be 
asked about the roles of the same CA I, 
IT and 111 isozymes in such tissues as 
liver and muscle, which incidentally 
probably also express a total of at least 
five CA genes. 
Metabolic Roles 
The presence of carbonic anhydrase in 
liver mitochondria has been confirmed 
in guinea pig and rat, and more recently 
reported from the mitochondria of rat 
I 
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with the CA 11-deficiency syndrome, 
some affected individuals have been 
reported with seemingly normal mental 
function in spite of extensive cerebral 
calcification". 
The differences in the pleiotropic 
human and mouse phenotypes serve as 
a warning that species-specific CA iso- 
zyme expression, and differences in 
interacting gene products, may com- 
promise the general use of animal 
models. 
As yet the molecular lesions respon- 
sible for the human and mouse CA 
deficiencies have not been determined. 
In the mice deficient in CA I1 the levels 
of CA I1 mRNA were not found to 
deviate from normal in all tissues 
examined, including brain and kidney, 
suggesting that a translational defect is 
responsible for the deficiency. No major 
deletion in the CA I1 gene from CA II- 
deficient humans was detected by South- 
ern blot analysis, and although a con- 
siderable portion of the defective genes 
found in patients from Belgium and 
KuwaV4 has been sequenced in our 
laboratory, no splicing or coding errors, 
or alternations in the promoter regions, 
have as yet been detected (P. J. Venta, 
unpublished). 
Finally, with regard to the control of 
gene expression, several features of the 
inherited CA deficiencies might be ex- 
pected to repay detailed analyses at the 
DNA level. One of the most intriguing is 
that the reduction of red-cell CA I to 
trace levels in pigtail macaques deficient 
in CA I is accompanied by a 6076 
reduction in the closely linked CA I1 
gene p r o d u ~ t . ~ . ' ~  It would obviously be 
of considerable interest to determine 
the molecular defect responsible for this 
' double deficiency ' such as the possi- 
bility of a mutation in a common 
regulatory cis-element. Another type of 
'double deficiency' is the possibility of 
trans-acting regulation implicated in the 
report of a deficiency of salivary CA VI 
in CA 11-deficient humans4' whose CA 
I1 and CA VI genes are known to be on 
chromosomes 8 and I ,  respectively.". l1 
(but not guinea pig) k i d n e ~ . ' ~ , ~ ~  It also 
may be present in the mitochondria of 
muscle fibers, oligodendrocytes, and 
gastric mucosa. The partial amino acid 
sequence of a CA isozyme (termed CA 
V) purified from guinea-pig mitochon- 
dria has been reported,32 and an exam- 
ination of the sequence indicates that it 
is coded by a CA gene distinct from 
those coding for the other CA isozymes. 
Because CA inhibitors (e.g. acetazol- 
amide) diminish the production of urea 
and glucose in hepatocytes, it appears 
that a role for CA V in mitochondria 
(which are permeable to CO,, but not 
HC03-), is to provide HC0,- ions for 
the synthesis of carbamyl phosphate 
and oxaloacetate formed in the first, 
intramitochondrial steps, respectively, 
of the urea cycle and gluconeogenesis. 
Possible roles for mitochondria1 CA in 
muscle, brain and gastric mucosa have 
yet to be fully explored. 
In addition, the production of HC0,- 
by CA is probably utilized for other 
anabolic syntheses requiring carboxyla- 
tion reactions such as fatty-acid syn- 
thesis as well as the synthesis of certain 
amino 
Inferring Function from Carbonic 
Anh ydrase Deficiencies 
We might expect to learn something 
about function of an enzyme if its 
absence results in an abnormality in the 
cell or tissue where it is normally 
expressed. Therefore it was somewhat 
unexpected to find that the inherited 
deficiency of CA I in humans and pig- 
tail macaques (homozygous for the 
deficiency gene) produced no detectable 
d e f e ~ t . ~  Although seemingly not as 
widely distributed as the CA I1 isozyme, 
CA I is nevertheless the second most 
abundant protein in red cells next to 
hemoglobin, and is found in the cells of 
a number of different tissues (Table I). 
Among the mechanisms which could 
compensate for the loss of the CA I 
activity would be that CA I1 is probably 
present in most cells where CA I is 
expressed and could substitute for the 
role of CA I. Because individuals defi- 
cient in CA I exhibit no detectable 
clinical symptoms on routine physical 
examination, nothing was learned about 
any specific function of CA I. On the 
other hand, a deficiency of CA I1 in 
humans was more informative, as its 
pleiotropic effects include impairments 
to growth, kidney function, bone re- 
sorption, and brain d e ~ e l o p m e n t . ~ ~  
Even this was not anticipated, because 
the wide distribution of CA I1 (Table I) 
would suggest that its deficiency would 
result in a syndrome of even greater 
severity. Again, as in the CA I defici- 
ency, the presence of CA I or other CA 
isozymes in a cell deficient in CA I1 
probably compensates for the absence 
of CA 11. This was nicely demonstrated 
in studies on intact erythrocytes from 
humans deficient in CA 11, where the 
CA I isozyme which is normally present 
at high levels appears to function quite 
adequately in carrying out the import- 
ant respiratory role of CA in the red 
In all likelihood, alternative bio- 
chemical pathways or mechanisms com- 
pensate for the loss of CA I1 in those 
cells. With this in mind, we might 
speculate on the consequences of de- 
ficiencies in the non-cytoplasmic CA 
isozymes such as the membrane-bound 
CA IV and mitochondrial CA V forms, 
where the probability of a 'back-up' 
CA seems less likely. Possibly, CA V 
deficiency would result in hyper- 
amoniaemia, and the absence of CA IV 
would produce critical dysfunctions in 
kidney and lung. 
An important finding from studies on 
the human CA 11-deficiency syndrome 
was that the osteopetrosis produced by 
a reduction in bone demineralization 
confirmed that the CA I1 normally 
present in osteoclasts is involved in 
bone resorption. However, osteo- 
petrosis was not observed in mice 
deficient in CA 11,36 alfhough CA I1 is 
known to be expressed in murine osteo- 
clasts. 
So far as kidney function is con- 
cerned, the renal tubulx acidosis ap- 
pears to be produced by an impairment 
of renal acidification and HC0,- re- 
absorption in both CA 11-deficient 
humans and mice, and is probably due 
to the absence of soluble CA I1 in the 
luminal cells of the distal and proximal 
tubules, which impedes the reclamation 
of HCO,-. 
The cerebral calcification associated 
with humans deficient in CA I1 has not 
been observed in CA 11-deficient mice. 
However, older CA 11-deficient mice do 
exhibit calcified plaques in the choroid 
plexus, in addition to rather extensive 
medial calcification of small arteries in 
a number of organs40. Whether the 
cerebral calcification found in older CA- 
11-deficient humans arises from vascular 
calcinosis has yet to be determined. CA 
I1 appears to be the most prevalent CA 
isozyme in brain and is characteristically 
found in oligodendrocytes. The associ- 
ation between CA I1 deficiency and 
mental impairment in humans is not 
understood. Although some degree of 
mental impairment is usually associated 
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Note added in proof 
Results of recent "0-exchange, ac- 
tivity measurements on human CA I1 in 
which Ala and Lys have been sub- 
stituted for His at position 64 by site- 
directed mutagenesis now indicate that 
His 64, as predicted, does contribute to 
the catalytic mechanism through its role 
in the proton transfer pathway (D. N. 
Silverman and S. Lindskog, personal 
communication; Tu, C. K. et al., 1989, 
Biochemistry, in the press). 
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